Difficulty: Medium
Average Score: 73%
Practice
Indicate the drug, which blocks both alphaÔéü and beta adrenoreceptors:
Correct answer
D
Rationale
In the context of advanced pharmacology across the lifespan, understanding the mechanisms of action of various drugs is crucial. In this question, the correct answer is D) Labetalol. Labetalol is a non-selective beta and alpha adrenergic receptor blocker. It acts on both alphaÔéü and beta adrenergic receptors, making it a unique antihypertensive medication with dual action.
Option A) Phentolamine is an alpha adrenergic receptor blocker, specifically an alphaÔéü blocker. It is used for conditions like hypertension and pheochromocytoma.
Option B) Prazosin is a selective alphaÔéü adrenergic receptor blocker commonly used in the management of hypertension and benign prostatic hyperplasia.
Option C) Propranolol is a non-selective beta-adrenergic receptor blocker. It is used in conditions like hypertension, angina, and arrhythmias.
Understanding the nuances of these drug classes is essential for healthcare professionals to make informed decisions when prescribing medications, especially in complex cases involving comorbidities or multiple conditions. Labetalol's dual mechanism of action can be particularly beneficial in certain clinical scenarios where both alpha and beta receptor blockade is warranted for optimal patient outcomes.
Option A) Phentolamine is an alpha adrenergic receptor blocker, specifically an alphaÔéü blocker. It is used for conditions like hypertension and pheochromocytoma.
Option B) Prazosin is a selective alphaÔéü adrenergic receptor blocker commonly used in the management of hypertension and benign prostatic hyperplasia.
Option C) Propranolol is a non-selective beta-adrenergic receptor blocker. It is used in conditions like hypertension, angina, and arrhythmias.
Understanding the nuances of these drug classes is essential for healthcare professionals to make informed decisions when prescribing medications, especially in complex cases involving comorbidities or multiple conditions. Labetalol's dual mechanism of action can be particularly beneficial in certain clinical scenarios where both alpha and beta receptor blockade is warranted for optimal patient outcomes.